UNH Manchester lecture series explores biotherapeutic technologies, February 11

Friday, January 24, 2020

Undermining a cornerstone of modern medicine, bacterial drug resistance has become an urgent threat to human health. A recent report by the CDC shows that, each year, antibiotic resistant bacteria and fungi cause more than 35,000 deaths and 2.8 million infections across the U.S. alone.

“A death from an antibiotic-resistant infection occurs about every 15 minutes, and a resistant infection occurs every 11 seconds,” said CDC Director Dr. Robert Redfield in a press conference about the report. “Antibiotic resistance threatens both our nation’s health and our global security.”

Stealth Technology for Biotherapeutics: A Case Study of Cutting-Edge Antibiotics
February 11 | 5:30 - 6:30 p.m.
UNH Manchester | Room 201

Learn more about the threat and the active development of cutting-edge solutions on February 11 at UNH Manchester’s lecture, “Stealth Technology for Biotherapeutics: A Case Study of Cutting-Edge Antibiotics.” Join Dr. Karl E. Griswold, associate professor of engineering at the Thayer School of Engineering at Dartmouth College, as he explores deadly drug-resistant bacteria and the promising medical advancements that may lead to safer and more effective biotherapies.

This event is presented by UNH Manchester’s biotechnology program as part of the Sidore Lecture Series, which seeks to offer programs to the University community and the state of New Hampshire that raise critical and sometimes controversial issues facing our society.

Stealth Technology for Biotherapeutics” will be held in room 201 at UNH Manchester on Tuesday, February 11 from 5:30 to 6:30 p.m. This event is free and open to the public thanks to the generous support of the Saul O Sidore Memorial Foundation. Parking is available on Commercial Street and in the lots surrounding 88 Commercial Street after 5 p.m.

learn more and RSVP